TELA
TELA Bio, Inc.Company with tickers: TELA
CIK
1561921
CUSIP
872381108
Shares Outstanding
44,766,146
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $19,059,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Cost of Revenue | — | ||||
| Gross Profit | $12,520,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Expenses | $23,046,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $2,343,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-10,526,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-12,273,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.21 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.21 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |